Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Lisata Therapeutics (LSTA) Receivables (2016 - 2025)

Historic Receivables for Lisata Therapeutics (LSTA) over the last 11 years, with Q3 2025 value amounting to $502000.0.

Lisata Therapeutics' Receivables changed N/A to $502000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $502000.0, marking a year-over-year change of. This contributed to the annual value of $900000.0 for FY2024, which is N/A changed from last year.
Latest data reveals that Lisata Therapeutics reported Receivables of $502000.0 as of Q3 2025.
In the past 5 years, Lisata Therapeutics' Receivables ranged from a high of $900000.0 in Q4 2024 and a low of $501000.0 during Q2 2025